118 STAT. 1558 PUBLIC LAW 108–357—OCT. 22, 2004 credit allowed under subsection (a) for the taxable year (other than the specified credits). ‘‘(B) SPECIFIED CREDITS.—For purposes of this sub section, the term ‘specified credits’ includes— ‘‘(i) for taxable years beginning after December 31, 2004, the credit determined under section 40, ‘‘(ii) the credit determined under section 45 to the extent that such credit is attributable to electricity or refined coal produced— ‘‘(I) at a facility which is originally placed in service after the date of the enactment of this paragraph, and ‘‘(II) during the 4 year period beginning on the date that such facility was originally placed in service’’. (b) CONFORMING AMENDMENTS.—Paragraph (2)(A)(ii)(II) and (3)(A)(ii)(II) of section 38(c) are each amended by inserting ‘‘or the specified credits’’ after ‘‘employee credit’’. (c) EFFECTIVE DATE.—Except as otherwise provided, the amend ments made by this section shall apply to taxable years ending after the date of the enactment of this Act. SEC. 712. INCLUSION OF PRIMARY AND SECONDARY MEDICAL STRATE GIES FOR CHILDREN AND ADULTS WITH SICKLE CELL DISEASE AS MEDICAL ASSISTANCE UNDER THE MED ICAID PROGRAM. (a) OPTIONAL MEDICAL ASSISTANCE.— (1) IN GENERAL.—Section 1905 of the Social Security Act (42 U.S.C. 1396d) is amended— (A) in subsection (a)— (i) by striking ‘‘and’’ at the end of paragraph (26); (ii) by redesignating paragraph (27) as paragraph (28); and (iii) by inserting after paragraph (26), the fol lowing: ‘‘(27) subject to subsection (x), primary and secondary med ical strategies and treatment and services for individuals who have Sickle Cell Disease; and’’; and (B) by adding at the end the following: ‘‘(x) For purposes of subsection (a)(27), the strategies, treatment, and services described in that subsection include the following: ‘‘(1) Chronic blood transfusion (with deferoxamine chela tion) to prevent stroke in individuals with Sickle Cell Disease who have been identified as being at high risk for stroke. ‘‘(2) Genetic counseling and testing for individuals with Sickle Cell Disease or the sickle cell trait to allow health care professionals to treat such individuals and to prevent symptoms of Sickle Cell Disease. ‘‘(3) Other treatment and services to prevent individuals who have Sickle Cell Disease and who have had a stroke from having another stroke.’’. (2) RULE OF CONSTRUCTION.—Nothing in subsections (a)(27) or (x) of section 1905 of the Social Security Act (42 U.S.C. 1396d), as added by paragraph (1), shall be construed as implying that a State medicaid program under title XIX of such Act could not have treated, prior to the date of enactment of this Act, any of the primary and secondary medical strategies 42 USC 1396d note. 26 USC 38 note.
�
